+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Veterinary/Animal Vaccines Market by Type (Aquaculture Vaccine, Companion Animal Vaccine, Livestock Vaccine), Disease (Aquaculture, Companion Animal, Livestock), Technology - Forecast 2024-2030- Product Image
Global Veterinary/Animal Vaccines Market by Type (Aquaculture Vaccine, Companion Animal Vaccine, Livestock Vaccine), Disease (Aquaculture, Companion Animal, Livestock), Technology - Forecast 2024-2030- Product Image
Sale

Global Veterinary/Animal Vaccines Market by Type (Aquaculture Vaccine, Companion Animal Vaccine, Livestock Vaccine), Disease (Aquaculture, Companion Animal, Livestock), Technology - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4986083
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary/Animal Vaccines Market size was estimated at USD 8.96 billion in 2023, USD 9.58 billion in 2024, and is expected to grow at a CAGR of 6.94% to reach USD 14.34 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Veterinary/Animal Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Veterinary/Animal Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Veterinary/Animal Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aptimmune Biologics, Inc., Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Santé Animale, China Animal Husbandry Industry Co., Ltd, Elanco AB, Endovac Animal Health, Heska Corporation, Hester Biosciences Limited, HIPRA, S.A., IDT Biologika GmbH, Indian Immunologicals Ltd., Merck & Co., Inc., Phibro Animal Health Corporation, Torigen Pharmaceuticals Inc., Virbac SA, and Zoetis Inc.

Market Segmentation & Coverage

This research report categorizes the Veterinary/Animal Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Aquaculture Vaccine
    • Companion Animal Vaccine
    • Livestock Vaccine
    • Porcine Vaccine
    • Poultry Vaccine
  • Disease
    • Aquaculture
    • Companion Animal
    • Livestock
    • Porcine
    • Poultry
  • Technology
    • Inactivated Vaccine
    • Live Attenuated Vaccine
    • Recombinant Vaccine
    • Toxoid Vaccine
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Veterinary/Animal Vaccines Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Veterinary/Animal Vaccines Market?
  3. What are the technology trends and regulatory frameworks in the Veterinary/Animal Vaccines Market?
  4. What is the market share of the leading vendors in the Veterinary/Animal Vaccines Market?
  5. Which modes and strategic moves are suitable for entering the Veterinary/Animal Vaccines Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Veterinary/Animal Vaccines Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of companion animal and livestock ownership
5.1.1.2. Improving veterinary care facilities in economies
5.1.1.3. Rising incidence of chronic diseases and accidental injuries in animals
5.1.2. Restraints
5.1.2.1. High storage costs for vaccines
5.1.3. Opportunities
5.1.3.1. Rising investments in veterinary vaccine R&D
5.1.3.2. Growing availability of pet insurance
5.1.4. Challenges
5.1.4.1. Inadequate surveillance and reporting systems
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Veterinary/Animal Vaccines Market, by Type
6.1. Introduction
6.2. Aquaculture Vaccine
6.3. Companion Animal Vaccine
6.4. Livestock Vaccine
6.5. Porcine Vaccine
6.6. Poultry Vaccine
7. Veterinary/Animal Vaccines Market, by Disease
7.1. Introduction
7.2. Aquaculture
7.3. Companion Animal
7.4. Livestock
7.5. Porcine
7.6. Poultry
8. Veterinary/Animal Vaccines Market, by Technology
8.1. Introduction
8.2. Inactivated Vaccine
8.3. Live Attenuated Vaccine
8.4. Recombinant Vaccine
8.5. Toxoid Vaccine
9. Americas Veterinary/Animal Vaccines Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Veterinary/Animal Vaccines Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Veterinary/Animal Vaccines Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Aptimmune Biologics, Inc.
13.1.2. Biogenesis Bago SA
13.1.3. Boehringer Ingelheim International GmbH
13.1.4. Brilliant Bio Pharma Private Limited
13.1.5. Ceva Santé Animale
13.1.6. China Animal Husbandry Industry Co., Ltd
13.1.7. Elanco AB
13.1.8. Endovac Animal Health
13.1.9. Heska Corporation
13.1.10. Hester Biosciences Limited
13.1.11. HIPRA, S.A.
13.1.12. IDT Biologika GmbH
13.1.13. Indian Immunologicals Ltd.
13.1.14. Merck & Co., Inc.
13.1.15. Phibro Animal Health Corporation
13.1.16. Torigen Pharmaceuticals Inc.
13.1.17. Virbac SA
13.1.18. Zoetis Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. VETERINARY/ANIMAL VACCINES MARKET RESEARCH PROCESS
FIGURE 2. VETERINARY/ANIMAL VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VETERINARY/ANIMAL VACCINES MARKET DYNAMICS
FIGURE 7. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 10. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 12. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. VETERINARY/ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. VETERINARY/ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. VETERINARY/ANIMAL VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY AQUACULTURE VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMAL VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PORCINE VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY POULTRY VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 12. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 18. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 32. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 34. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 51. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. INDIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 54. INDIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. JAPAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. JAPAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 60. JAPAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. THAILAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. THAILAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 78. THAILAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. DENMARK VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 88. DENMARK VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. EGYPT VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. EGYPT VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 91. EGYPT VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. FINLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. FINLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 94. FINLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. FRANCE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 97. FRANCE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 100. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. ITALY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. ITALY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 106. ITALY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. NORWAY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. NORWAY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 115. NORWAY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. POLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. POLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 118. POLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. QATAR VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. QATAR VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 121. QATAR VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. SPAIN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 133. SPAIN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. TURKEY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 142. TURKEY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. VETERINARY/ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 150. VETERINARY/ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 151. VETERINARY/ANIMAL VACCINES MARKET LICENSE & PRICING

Companies Mentioned

  • Aptimmune Biologics, Inc.
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited
  • Ceva Santé Animale
  • China Animal Husbandry Industry Co., Ltd
  • Elanco AB
  • Endovac Animal Health
  • Heska Corporation
  • Hester Biosciences Limited
  • HIPRA, S.A.
  • IDT Biologika GmbH
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • Torigen Pharmaceuticals Inc.
  • Virbac SA
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 9.58 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.34 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Global Veterinary Pharmaceuticals Market by Product (Veterinary Antibiotics, Veterinary Parasiticides, Veterinary Vaccines), Vaccines (Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines), Antibiotics, End User, Animal - Forecast 2024-2030 - Product Image

Global Veterinary Pharmaceuticals Market by Product (Veterinary Antibiotics, Veterinary Parasiticides, Veterinary Vaccines), Vaccines (Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines), Antibiotics, End User, Animal - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Global Companion Animal Vaccine Market by Product Type (Attenuated Live Vaccine, Conjugate Vaccine, DNA Vaccine), Animal Type (Canine, Equine, Feline), Distribution Channel - Forecast 2024-2030 - Product Image

Global Companion Animal Vaccine Market by Product Type (Attenuated Live Vaccine, Conjugate Vaccine, DNA Vaccine), Animal Type (Canine, Equine, Feline), Distribution Channel - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Companion Animal Vaccines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts- 2023 to 2031 - Product Image

Companion Animal Vaccines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts- 2023 to 2031

  • Report
  • 111 Pages
  • Global
From
Global Veterinary/Animal Vaccine Market Analysis & Forecast to 2023-2033: Market By Product; By Animal; By Route of Administration; By End-user; and by Region - Product Image

Global Veterinary/Animal Vaccine Market Analysis & Forecast to 2023-2033: Market By Product; By Animal; By Route of Administration; By End-user; and by Region

  • Report
  • 145 Pages
  • Global
From
Global Veterinary Vaccines Market Report and Forecast 2023-2031 - Product Image

Global Veterinary Vaccines Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.